2021 Fiscal Year Final Research Report
Urolithiasis diagnosis and recurrence prediction method by urinary aberrant glycosylation of osteopontin and related glycosyltransferases
Project/Area Number |
19K18570
|
Research Category |
Grant-in-Aid for Early-Career Scientists
|
Allocation Type | Multi-year Fund |
Review Section |
Basic Section 56030:Urology-related
|
Research Institution | Tohoku Medical and Pharmaceutical University |
Principal Investigator |
Anan Go 東北医科薬科大学, 医学部, 助教 (70816222)
|
Project Period (FY) |
2019-04-01 – 2022-03-31
|
Keywords | 尿路結石 / オステオポンチン / 糖鎖生物学 |
Outline of Final Research Achievements |
Osteopontin (OPN) is a matrix glycoprotein of urinary calculi. This study aims to identify the role of aberrant glycosylation of OPN in urolithiasis. We retrospectively measured urinary glycosylated OPN normalized by urinary full-length-OPN (uFL-OPN) levels in 110 urolithiasis patients and 157 healthy volunteers (HVs). The uFL-OPN levels were measured using enzyme-linked immunosorbent assay and glycosylated OPN was measured using a lectin array and lectin blotting. In the study, we found that the uFL-OPN adjusted urine total protein was significantly lower in stone forming patients than in HVs (p < 0.001) and that urinary Gal3C-S-OPN/uFL-OPN level was significantly higher in stone forming patients than in HVs (p < 0.001). Immunoblotting and lectin blotting analysis showed that the band intensity of uFL-OPN in the HVs was higher than that of the uFL-OPN in the stone forming patients, whereas the band intensity of LEL reactive OPN clearly increased in stone forming urolithiasis patients.
|
Free Research Field |
尿路結石
|
Academic Significance and Societal Importance of the Research Achievements |
尿路結石形成に必須とされている1つがオステオポンチン(OPN)である。OPNは糖タンパク質である。これまで、尿路結石の研究分野においてOPNの糖鎖構造の変化と結石形成との関連についての研究はない。 今回、私たちはOPNの糖鎖に着目した。尿路結石患者では健常者と比較して尿中OPN濃度は低下するにもかかわらず、糖鎖変異OPN(Gal3C-S-OPN)とポリラクトサミンOPNが有意に増加した。以上より、尿路結石患者の尿中OPNの糖鎖構造変化が明らかとなった。この糖鎖変異OPNが結石形成にどのように関わっているのか、糖鎖変異OPNの機能解析を含めて今後検討が必要である。
|